Chin fat, double chin, skin laxity. However you refer to it, submental fullness is an aesthetic condition that affects more than half our population. With a multitude of causes, including genetic makeup, aging, and weight gain, it can be a source of great embarrassment and low self-confidence for men and women alike.
Quite often, excess submental fat is resistant to the benefits of a healthy diet and regular exercise, and until recently, surgery was required to effectively correct the condition. With the introduction of BELKYRA™, a nonsurgical injectable treatment also known as KYBELLA® in the United States, it's now possible to permanently and nonsurgically correct a double chin for patients in Kitchener-Waterloo, Guelph, London, and surrounding areas.
To see if the double chin treatment is right for you, please request a consultation online or give us a call at (519) 746-1132 to schedule your appointment.
Earn rewards points with the Brilliant Distinctions program whenever you purchase BOTOX COSMETIC®, JUVÉDERM®, or BELKYRA™ treatments or LATISSE®. Redeem your points to save on future treatments.Learn More
BELKYRA is a safe and effective injectable treatment. The procedure is the leading nonsurgical option for submental fullness today, and when performed by a skilled and trained medical specialist, the double chin treatment helps to permanently reduce the fat layer below the chin, for a refined and rejuvenated jawline.
The injections are composed of a synthetic form of deoxycholic acid, a fat-metabolizing agent that is found naturally in our bodies. Once injected, this substance works to break down the membranes of targeted fat cells, causing them to collapse and be processed naturally by the body.
If you are a healthy adult with unwanted fat below the chin, BELKYRA injections may be right for you. Fat accumulation in this area is often hereditary, which means that even those who are in great shape may still struggle with a double chin, despite their most diligent efforts at diet and exercise.
Our surgeons and skin care professionals work with you to decide which treatment option is best. We can evaluate your condition and discuss other important factors, such as downtime, budget, and lifestyle, to find the right fit for your needs.
Treatments are quick and simple, similar to other injectable services at our clinic. We begin by cleansing your neck and providing a local anesthetic to ensure your comfort. Next, we plan where we want to administer the injections by making small marks on your skin. Most people require several injections, placed about a centimeter apart, for optimal results. We perform the injections quickly: The whole process takes only about 30 minutes.
There is very little downtime associated with BELKYRA, and patients can expect to return to their normal activities immediately following treatment. Patients may experience some swelling, tenderness and bruising around the injection site, which should dissipate within a few days.
Depending on the amount of fat in the area, the procedure will be repeated 2 to 6 times over several months for optimal outcomes.
Patients can expect to see a gradual, permanent reduction of fullness in the area over a period of 2 to 4 weeks following each treatment, eventually resulting in the desired facial profile. Some patients may also notice skin tightening under the chin following treatment, resulting in a more youthful, contoured neckline.
Your results can last indefinitely. The body does not create new fat cells — so once they are broken down and flushed out by the body, they are gone for good. Other fat cells that remain in your body can still enlarge or shrink as your weight shifts, however, so we advise maintaining a stable weight to optimize your results. You can enjoy your improved contours for many years to come.
If you believe you may be a candidate for BELKYRA treatments, contact The Cosmetic Surgery Clinic today to request a consultation.
BELKYRA™ is a trademark of Kythera Biopharmaceuticals, Inc., an Allergan affiliate, used under license by Actavis Specialty Pharmaceuticals Co.